{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:31Z","timestamp":1791489691560,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12072-024-10761-8","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:40:06Z","timestamp":1734612006000},"page":"118-130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rheumatoid factor levels indicate cryoglobulinemia severity in hepatitis B e antigen-negative hepatitis B virus carriers: a 7-year prospective cohort study"],"prefix":"10.1007","volume":"19","author":[{"given":"Jen-Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Guei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-4401","authenticated-orcid":false,"given":"Ming-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"issue":"2","key":"10761_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2468-1253(20)30307-1","volume":"6","author":"M Tan","year":"2021","unstructured":"Tan M, Bhadoria AS, Cui F, Tan A, Van Holten J, Easterbrook P, et al. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(2):106\u2013119. https:\/\/doi.org\/10.1016\/S2468-1253(20)30307-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10761_CR2","doi-asserted-by":"crossref","unstructured":"GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7(9):796\u2013829.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"10761_CR3","unstructured":"http:\/\/www.fma.org.tw\/2010spring\/S14-1.html"},{"issue":"3","key":"10761_CR4","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3390\/ijms23031552","volume":"23","author":"ML Chang","year":"2022","unstructured":"Chang ML, Liaw YF. Hepatitis B flare in Hepatitis B e antigen-negative patients: a complicated cascade of innate and adaptive immune responses. Int J Mol Sci. 2022;23(3):1552","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10761_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41575-019-0197-8","volume":"16","author":"YF Liaw","year":"2019","unstructured":"Liaw YF. Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection. Nat Rev Gastroenterol Hepatol. 2019;16(10):631\u2013641","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9663","key":"10761_CR6","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582\u2013592","journal-title":"Lancet"},{"issue":"5","key":"10761_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2005.05.029","volume":"43","author":"P Cacoub","year":"2005","unstructured":"Cacoub P, Saadoun D, Bourli\u00e8re M, Khiri H, Martineau A, Benhamou Y, et al. Hepatitis B virus genotypes and extrahepatic manifestations. J Hepatol. 2005;43(5):764\u2013770","journal-title":"J Hepatol"},{"issue":"9","key":"10761_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","volume":"128","author":"P Cacoub","year":"2015","unstructured":"Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D. Cryoglobulinemia vasculitis. Am J Med. 2015;128(9):950\u2013955","journal-title":"Am J Med"},{"issue":"3","key":"10761_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7326\/0003-4819-87-3-287","volume":"87","author":"Y Levo","year":"1977","unstructured":"Levo Y, Gorevic PD, Kassab HJ, Tobias H, Franklin EC. Liver involvement in the syndrome of mixed cryoglobulinemia. Ann Intern Med. 1977;87(3):287\u2013292","journal-title":"Ann Intern Med"},{"issue":"7","key":"10761_CR10","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.dld.2016.03.018","volume":"48","author":"C Mazzaro","year":"2016","unstructured":"Mazzaro C, Dal Maso L, Urraro T, Mauro E, Castelnovo L, Casarin P, et al. Hepatitis B virus related cryoglobulinemic vasculitis: a multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC. Dig Liver Dis. 2016;48(7):780\u2013784","journal-title":"Dig Liver Dis"},{"key":"10761_CR11","unstructured":"Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G, et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM. 1995;88(2):115\u201326"},{"key":"10761_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.580271","volume":"12","author":"W Bai","year":"2021","unstructured":"Bai W, Zhang L, Zhao J, Zhang S, Zhou J, Leng X, et al. Renal involvement and HBV infection are common in chinese patients with cryoglobulinemia. Front Immunol. 2021;12: 580271","journal-title":"Front Immunol"},{"issue":"Suppl 3","key":"10761_CR13","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1093\/infdis\/jiad016","volume":"228","author":"RN Chien","year":"2023","unstructured":"Chien RN, Lu SN, Hui-Min WuG, Yang WW, Pwu RF, Liu CL, et al. Policy and strategy for Hepatitis C virus elimination at the national level: experience in Taiwan. J Infect Dis. 2023;228(Suppl 3):S180\u2013S188","journal-title":"J Infect Dis"},{"issue":"3","key":"10761_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cmi.2019.06.018","volume":"26","author":"YT Cheng","year":"2020","unstructured":"Cheng YT, Cheng JS, Lin CH, Chen TH, Lee KC, Chang ML. Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study. Clin Microbiol Infect. 2020;26(3):366\u2013372","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10761_CR15","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.cgh.2020.01.018","volume":"18","author":"ML Chang","year":"2020","unstructured":"Chang ML, Cheng JS, Chien RN, Liaw YF. Hepatitis flares are associated with better outcomes than no flare in patients with decompensated cirrhosis and chronic Hepatitis B virus infection. Clin Gastroenterol Hepatol. 2020;18(9):2064-2072.e2","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10761_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"EASL","year":"2017","unstructured":"EASL. Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u2013398","journal-title":"J Hepatol"},{"key":"10761_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/ajh.22023","volume":"86","author":"G Motyckova","year":"2011","unstructured":"Motyckova G, Murali M. Laboratory testing for cryoglobulins. Am J Hematol. 2011;86:500\u2013502","journal-title":"Am J Hematol"},{"issue":"1","key":"10761_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3748\/wjg.v27.i1.19","volume":"27","author":"CR Wang","year":"2021","unstructured":"Wang CR, Tsai HW. Human hepatitis viruses-associated cutaneous and systemic vasculitis. World J Gastroenterol. 2021;27(1):19\u201336","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10761_CR19","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1111\/dom.15622","volume":"26","author":"ML Chang","year":"2024","unstructured":"Chang ML, Tai J, Cheng JS, Chen WT, Yang SS, Chiu CH, et al. Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: a 3-year prospective cohort study. Diabetes Obes Metab. 2024;26(7):2969\u20132978","journal-title":"Diabetes Obes Metab"},{"key":"10761_CR20","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jhep.2014.08.033","volume":"61","author":"ML Chang","year":"2014","unstructured":"Chang ML, Liaw YF. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol. 2014;61:1407\u20131417","journal-title":"J Hepatol"},{"issue":"4","key":"10761_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/jcm10040817","volume":"10","author":"JS Cheng","year":"2021","unstructured":"Cheng JS, Lin YS, Hu JH, Chang MY, Ku HP, Chien RN, et al. Impact of interferon-based therapy on hepatitis C-associated rheumatic diseases: a nationwide population-based cohort study. J Clin Med. 2021;10(4):817","journal-title":"J Clin Med"},{"issue":"6","key":"10761_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12072-019-09989-6","volume":"13","author":"YF Liaw","year":"2019","unstructured":"Liaw YF. Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift. Hepatol Int. 2019;13(6):665\u2013673","journal-title":"Hepatol Int"},{"issue":"22","key":"10761_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003609","volume":"95","author":"WC Lee","year":"2016","unstructured":"Lee WC, Lee CS, Wang YC, Cheng CH, Wu TH, Lee CF, et al. Validation of the model for end-stage liver disease score criteria in urgent liver transplantation for acute flare up of hepatitis B. Medicine (Baltimore). 2016;95(22): e3609","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10761_CR24","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/archinte.1990.00390170087019","volume":"150","author":"BJ McMahon","year":"1990","unstructured":"McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med. 1990;150(5):1051\u20134","journal-title":"Arch Intern Med."},{"issue":"17","key":"10761_CR25","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2174\/138161208784746824","volume":"14","author":"S Ferri","year":"2008","unstructured":"Ferri S, Muratori L, Lenzi M, Granito A, Bianchi FB, Vergani D. HCV and autoimmunity. Curr Pharm Des. 2008;14(17):1678\u20131685","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10761_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.42671","volume":"76","author":"PA Monach","year":"2024","unstructured":"Monach PA. Complement. Arthritis Rheumatol. 2024;76(1):1\u20138","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10761_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s13238-012-2924-6","volume":"3","author":"KR Mayilyan","year":"2012","unstructured":"Mayilyan KR. Complement genetics, deficiencies, and disease associations. Protein Cell. 2012;3(7):487\u2013496","journal-title":"Protein Cell"},{"key":"10761_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100017","volume":"2","author":"T Lung","year":"2019","unstructured":"Lung T, Sakem B, Risch L, W\u00fcrzner R, Colucci G, Cerny A, et al. The complement system in liver diseases: evidence-based approach and therapeutic options. J Transl Autoimmun. 2019;2: 100017","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"10761_CR29","doi-asserted-by":"publisher","first-page":"18407","DOI":"10.1038\/s41598-021-98010-y","volume":"11","author":"R Wang","year":"2021","unstructured":"Wang R, Wu Y, Zheng B, Zhang X, An D, Guo N, et al. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection. Sci Rep. 2021;11(1):18407","journal-title":"Sci Rep"},{"issue":"5","key":"10761_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40265-023-01843-2","volume":"83","author":"ML Chang","year":"2023","unstructured":"Chang ML, Liaw YF. Emerging therapies for chronic Hepatitis B and the potential for a functional cure. Drugs. 2023;83(5):367\u2013388","journal-title":"Drugs"},{"issue":"3","key":"10761_CR31","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/v13030464","volume":"13","author":"ML Chang","year":"2021","unstructured":"Chang ML, Chang SW, Chen SC, Chien RN, Hsu CL, Chang MY, et al. Genetic association of Hepatitis C-related mixed cryoglobulinemia: a 10-year prospective study of asians treated with antivirals. Viruses. 2021;13(3):464","journal-title":"Viruses"},{"issue":"10","key":"10761_CR32","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.medcli.2021.11.017","volume":"158","author":"S Retamozo","year":"2022","unstructured":"Retamozo S, Quartuccio L, Ramos-Casals M. Cryoglobulinemia. Med Clin (Barc). 2022;158(10):478\u2013487","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"10761_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","volume":"79","author":"MH Le","year":"2023","unstructured":"Le MH, Le DM, Baez TC, Wu Y, Ito T, Lee EY, et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons. J Hepatol. 2023;79(2):287\u2013295","journal-title":"J Hepatol"},{"key":"10761_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/439018","volume":"2012","author":"PD Gorevic","year":"2012","unstructured":"Gorevic PD. Rheumatoid factor, complement, and mixed cryoglobulinemia. Clin Dev Immunol. 2012;2012: 439018","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"10761_CR35","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.4049\/jimmunol.125.4.1530","volume":"125","author":"D Geltner","year":"1980","unstructured":"Geltner D, Franklin EC, Frangione B. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol. 1980;125(4):1530\u20131535","journal-title":"J Immunol"},{"issue":"11","key":"10761_CR36","first-page":"2199","volume":"31","author":"D Sene","year":"2004","unstructured":"Sene D, Ghillani-Dalbin P, Thibault V, Guis L, Musset L, Duhaut P, et al. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol. 2004;31(11):2199\u20132206","journal-title":"J Rheumatol"},{"issue":"3","key":"10761_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/joim.12913","volume":"286","author":"C Mazzaro","year":"2019","unstructured":"Mazzaro C, Dal Maso L, Visentini M, Gitto S, Andreone P, Toffolutti F, et al. Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review. J Intern Med. 2019;286(3):290\u2013298","journal-title":"J Intern Med."},{"issue":"9813","key":"10761_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379(9813):348\u2013360. https:\/\/doi.org\/10.1016\/S0140-6736(11)60242-0","journal-title":"Lancet"},{"key":"10761_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2023.199212","volume":"336","author":"HX Han","year":"2023","unstructured":"Han HX, Su W, Zhou DB, Li J, Cao XX. Hepatitis B virus-related cryoglobulinemia: clinical characteristics, virological features, and treatment. Virus Res. 2023;336: 199212","journal-title":"Virus Res"},{"issue":"6","key":"10761_CR40","first-page":"1231","volume":"38","author":"S Scarpato","year":"2020","unstructured":"Scarpato S, Galassi G, Monti G, Mazzaro C, Mascia MT, Scaini P, et al. Italian Group for the Study of Cryoglobulinaemia (GISC). Peripheral neuropathy in mixed cryoglobulinaemia: clinical assessment and therapeutic approach. Clin Exp Rheumatol. 2020;38(6):1231\u20131237","journal-title":"Clin Exp Rheumatol."},{"issue":"21","key":"10761_CR41","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.3390\/jcm11216247","volume":"11","author":"C Mazzaro","year":"2022","unstructured":"Mazzaro C, Adinolfi LE, Pozzato G, Nevola R, Zanier A, Serraino D, et al. Extrahepatic manifestations of chronic HBV infection and the role of antiviral therapy. J Clin Med. 2022;11(21):6247","journal-title":"J Clin Med"},{"issue":"6","key":"10761_CR42","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1542-3565(05)00018-2","volume":"3","author":"L Muratori","year":"2005","unstructured":"Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, et al. Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol. 2005;3(6):595\u2013603","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10761-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10761-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10761-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T12:45:10Z","timestamp":1740228310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10761-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10761"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10761-8","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval for the research protocol was obtained from the Chang Gung Memorial Hospital institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical disclosure statements"}},{"value":"Informed consent was obtained in writing from each patient. Registry and the Registration No. of the study\/trial: IRB No: 202001433B0; 20231005B0.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Chang Gung Memorial Hospital institutional review board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"The authors have completed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting checklist.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reporting checklist"}}]}}